Rush University Medical Center has received a $5 million donation from Chicago philanthropists Robert and Emily King that will accelerate blood cancer immunotherapy research and the development of new treatment options.
Mia Levy, MD, PhD, a breast cancer specialist and nationally recognized precision oncology leader, has been appointed director of the Rush University Cancer Center.
Rush is testing whether a vaccine can help people’s own immune system slow the spread of glioblastomas, a deadly form of brain cancer.
The Commission on Cancer has granted the Rush University Cancer Center accreditation through 2020 following an extensive onsite survey that demonstrated how Rush has exceeded 34 quality of care standards and sustained excellence across four domains of care: access and service, satisfaction and well-being, quality of care and cancer outcomes.
Dana Hayden, MD, thinks that you’re never too young to be screened for colon cancer — provided you have symptoms of the disease, that is.
Surgical oncologist Dr. Cristina O’Donoghue is one of less than 30 surgeons in the country to trained to perform isolated limb infusion, which delivers high doses of chemotherapy to an affected arm or leg but not the rest of the body.
Rush University Medical Center has received a $275,000 grant from the National Institutes of Health for research aimed at developing a blood test to detect lung cancer.
Certain cancer cells stave off their death with help from a particular molecule in a protein involved in the body’s immune system response, a research team at Rush University Medical Center has found.
Cancer experts at Rush discuss the role of genetics in the prevention, detection and treatment of cancer.
Sales of a limited edition White Sox cap with a cancer awareness ribbon in part benefit pediatric cancer research and treatment at Rush.